​

CNS Pharmaceuticals Ownership | Who Owns CNS Pharmaceuticals?

OverviewForecastFinancialsChart

CNS Pharmaceuticals Ownership Summary

CNS Pharmaceuticals is owned by 21.53% institutional investors, 0.07% insiders, and 78.40% retail investors. Fidelity Extended Market Index is the top mutual fund, with 2.75% of its assets in CNS Pharmaceuticals shares.

CNSP Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockCNS Pharmaceuticals21.53%0.07%78.40%
SectorHealthcare Stocks 35.58%11.87%52.55%
IndustryBiotech Stocks 35.75%11.83%52.41%

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 20261122.22%145,59617.19%212.74%650.00%--100.00%
Dec 31, 2025912.50%124,237404.70%28144.44%4-1-75.00%
Sep 30, 20258-20.00%24,616-95.20%43.30%4-50.00%4-
Jun 30, 20251042.86%512,7451163.11%11520.83%8166.67%--100.00%
Mar 31, 20257-56.25%40,594-98.49%110.29%3-80.00%4300.00%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Fidelity Extended Market Index22.29K2.75%15.92K
Spartan Extended Market Index Pool F812.000.14%-
Fidelity Series Total Market Index555.000.07%-
JHVIT Total Stock Market Index I2.38K0.04%-
Spartan Total Market Index Pool G345.000.04%-
Spartan Extended Market Index Pool E145.000.01%42.00
Vanguard Institutional Extnd Mkt Idx Tr23.000.00%-
NT Ext Eq Mkt Indx Fd DC Lending Tier 52.000.00%1.00
NT Ext Equity Mkt Idx Fd - L9.00--
SSgA U.S. Total Market Index Strategy5.00-1.00

Recent Insider Transactions

DateNameRoleActivityValue
May 18, 2026Charles Faith L.-Buy$34.00K
Feb 01, 2024Gumulka Jerzy-Buy$10.00K
Feb 01, 2024Evans Carl Anthony-Buy$10.00K
Feb 01, 2024Downs Christopher Chief Financial OfficerBuy$20.00K
Feb 01, 2024Climaco John M Chief Executive OfficerBuy$50.00K

Insider Transactions Trends

DateBuySell
2026 Q21-
2026 Q1--
2025 Q4--
2024 Q3--
2024 Q2--

CNSP Ownership FAQ

Who Owns CNS Pharmaceuticals?

CNS Pharmaceuticals shareholders are primarily institutional investors at 21.53%, followed by 0.07% insiders and 78.40% retail investors. The average institutional ownership in CNS Pharmaceuticals's industry, Biotech Stocks , is 35.75%, which CNS Pharmaceuticals falls below.

Does Blackrock own CNS Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of CNS Pharmaceuticals.

Who is the top mutual fund holder of CNS Pharmaceuticals shares?

Fidelity Extended Market Index is the top mutual fund holder of CNS Pharmaceuticals shares, with 2.75% of its total shares outstanding invested in 22.29K CNS Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools